H2020Individual fellowship2016–2018

BSSTD · Bioelectrochemical Sensing of Sexually Transmitted Diseases

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-09-15 → 2018-09-14
EU contribution
€195,455
Participants
1
Scheme
MSCA-IF-EF-RI

Lines connect the coordinator with its partners.

Results in brief

Bioelectrochemical Sensing of Sexually Transmitted Diseases

"The detection of sexually transmitted diseases (STDs) has become a serious medical concern around the globe, as the number of reported cases increases every year, particularly in the United Kingdom.1 Infection with STDs, such as Gonorrhea and Chlamydia can result in long term health issues, such as infertility, reproductive tract cancer, and poor perinatal outcome. The successful treatment of these diseases depends on a quick and reliable method of diagnosis. The funded project aimed for the development of a detection method for bacteria, associated with STDs, based on bioelectrochemical techniques. The project’s methodology is based on the identification of a redox couple, functioning as electron donor for bacterial oxidases, the specific binding of bacteria to a macroelectrode and the electrochemical recognition of immobilized bacteria at the macroelectrode. The proposed technique makes use of a biochemical test for aerobic bacteria, the oxidase test, by adapting it for electrochemical detection. In doing so, high selectivity is achieved by targeted binding of living bacteria to immobilized antibodies on an electrode, whereas sensitivity is strongly increased through the localized electrochemical detection of the oxidase test product. The proposed detection principle has the potential to be transferred to all oxidase-positive bacteria. The detection method can thus find widespread use for a large number of pathogens in health, veterinary care, food, and pharma industries. This project is structured into 6 main objectives: 1) Identification of a redox couple functioning as electron donor for bacterial oxidases, 2) Specific binding of bacteria to a gold macroelectrode, 3) Proof of concept: Combining objectives #1 and #2, 4) Controls: Testing for false-positive and false-negative results, 5) Varying target cultures, 6) Transfer of the chemical principle onto disposable screen printed electrodes towards the assembly of a biosensing device. In conclusion, all objectives and work packages outlined in the proposal were achieved, whereby 7 manuscripts were published in scientific high quality peer-reviewed journals, including Chemical Science. Another manuscript is currently in preparation for submission. The established electrochemical concept for the detection of the pathogens E. coli and N gonorrhoea lead to the filing of a patent application and steps are currently underway to bringing the established chemical principle to the commercial market. "

Data: CORDIS, © European Union

Project objective

The detection of sexually transmitted diseases (STDs) has become a serious medical concern around the globe, as the number of reported cases increases every year, particularly in the United Kingdom. Infection with STDs, such as Gonorrhea and Chlamydia can result in long term health issues, such as infertility, reproductive tract cancer, and poor perinatal outcome. The successful treatment of these diseases depends on a quick and reliable method of diagnosis, which will be the topic of this proposal. The overall goal of the proposed research is to develop a detection method for bacteria, associated with STDs, based on bioelectrochemical techniques.Specific objectives of the proposed research consist of the identification of a redox couple functioning as electron donor for bacterial oxidases, the specific binding of bacteria to a macroelectrode, the electrochemical recognition of immobilized bacteria at the macroelectrode, testing for false-positive and false-negative results, the varying of target cultures to extend the scope of the proposed research, and finally, the assembly of a biosensing device using disposable screen printed electrodes.The proposed technique will make use of a biochemical test for aerobic bacteria, the oxidase test, by adapting it for electrochemical detection. In doing so, high selectivity will be achieved by targeted binding of living bacteria to immobilized antibodies on an electrode, whereas sensitivity will be strongly increased through the localized electrochemical detection of the oxidase test product. To demonstrate the usefulness and applicability to medical diagnostics, an approach is proposed to transfer the presented proof of concept to portable screen printed electrodes, which will permit the routine use of this concept in a bioelectrochemical handheld device. The proposed research answers the European Commission’s call for the development of new technologies in the health sector and an urgent need in public health monitoring.

Original text from CORDIS.

Participants

  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordCoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union